Sort
15,440 grants matching “organoids”
MRI: Acquisition of a digital spatial molecular profiler to advance research and training at a Hispanic-serving institution
$430,257Brian P Hermann · University Of Texas At San Antonio · · FY2020 · BIO
The Paracrine Regulation of Mast Cells During Biliary/Cholangiocyte Repair and Damage
$430,234Heather L Francis · Indiana University Indianapolis · R01 · FY2024 · DK
Discovery and therapeutic targeting of biological determinants of lung cancer health disparities
$430,226Sharon R. Pine · Rbhs -Cancer Institute Of New Jersey · R01 · FY2021 · CA
EV-D68 genetic neuropathogenesis determinants
$430,170Megan Culler Freeman · University Of Pittsburgh At Pittsburgh · R21 · FY2025 · AI
Multidimensional characterization of RNAs and signals in single intestinal cells
$430,091Ramesh A Shivdasani · Dana-Farber Cancer Inst · R01 · FY2014 · DK
A cancer-derived truncating mutation in disease penetrance and progression of MSI CRC
$429,989Chengyu Liang · Wistar Institute · R01 · FY2020 · CA
Core B: Translational, Cellular and Molecular Analysis
$429,963Manuel R Amieva · Stanford University · P01 · FY2024 · CA
Understanding the mechanisms of iron addiction in colon cancer
$429,787Yatrik M Shah · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Role of STEAP2 protein in hepatocarcinogenesis
$429,775Luzhe Sun · University Of Texas Hlth Science Center · R01 · FY2022 · CA
Role of STEAP2 protein in hepatocarcinogenesis
$429,775Luzhe Sun · University Of Texas Hlth Science Center · R01 · FY2023 · CA
The Impact of hiPSC-Derived Microglia in Human Brain Development in Health and Disease
$429,655Alysson R. Muotri · University Of California, San Diego · R01 · FY2024 · NS
In vitro modeling of blood brain barrier dysfunction on a chip to elucidate the pathogenesis of cerebral malaria
$429,639Linnie Golightly · Weill Medical Coll Of Cornell Univ · R33 · FY2024 · HL
Investigation of Human Gut-Derived Mesenchymal Stem Cells for Cellular Therapy
$429,545Raghavan Chinnadurai · Mercer University Macon · R15 · FY2024 · AI
RB tumor suppressor as a therapeutic target in ER-positive breast cancer
$429,531Erik Knudsen · Roswell Park Cancer Institute Corp · R01 · FY2020 · CA
RB tumor suppressor as a therapeutic target in ER-positive breast cancer
$429,531Erik Knudsen · Roswell Park Cancer Institute Corp · R01 · FY2021 · CA
Cancer-prone cell states of the fallopian tubal epithelium
$429,513Alexander Y Nikitin · Cornell University · R01 · FY2021 · CA
Cancer-prone cell states of the fallopian tubal epithelium
$429,513Alexander Y Nikitin · Cornell University · R01 · FY2025 · CA
Drug Mechanism of Action-based targeting of tumor subpopulations
$429,473Andrea Califano · Columbia University Health Sciences · U54 · FY2024 · CA
Metabolic basis of the NADPH-independent disulfide reductase system in mouse liver
$429,382Edward E Schmidt · Montana State University - Bozeman · R01 · FY2022 · DK
Unravelling MyD88-dependent and independent mucosal immunity to Toxoplasma
$429,331Eric Y Denkers · University Of New Mexico · R01 · FY2025 · AI
Macrophage LRRK2 activity regulates gut epithelial homeostasis
$429,180Ta-Chiang Liu · Washington University · R01 · FY2024 · DK
Evaluation of the Efficacy of Trametinib + Navitoclax in recurrent ovarian carcinoma
$429,166Ursula Anne Matulonis · Dana-Farber Cancer Inst · P50 · FY2020 · CA
Development of a new marine natural product for the treatment of cryptosporidiosis, an AIDS-defining disease
$429,156Roberta M O'Connor · University Of Minnesota · R01 · FY2021 · AI
FGFR Signaling in Liver Injury and Fibrosis
$429,133Nirmala Mavila · Cedars-Sinai Medical Center · R01 · FY2023 · DK
Intersection of cytoskeletal regulation with tumor cell metabolism
$429,079Gina Lynn Razidlo · Mayo Clinic Rochester · R01 · FY2024 · CA